The type of DNA damage response after Decitabine treatment depends on the level of DNMT activity
T. Aumer, L. Bergmayr, S. Kartika, T. Zeng, Q. Ge, G. Giorgio, M. Daether, A. J. Hess, S. Michalakis, F. R. Traube
This study shows that Decitabine's DNA damage response depends on DNMT activity levels, with different repair pathways activated under varying conditions.
bioRxiv · Sep 2, 2023Biochemistry